A meta‑analysis of the safety and efficacy of bosentan therapy combined with prostacyclin analogues or phosphodiesterase type‑5 inhibitors for pulmonary arterial hypertension
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.